Search - tctmd.com

Displaying 201 - 220 of 2791

Sort: Relevancy | Date

Surgeons Formalize Support for ESC’s Stance on Revascularization in CCS

News Daily News

Surgeons Formalize Support for ESC’s Stance on CCS Revascularization

Michael O'Riordan

January 20, 2025

News Daily News

Misleading Statements Common in Online Ads for Compounded GLP-1s

L.A. McKeown

January 20, 2025

News Daily News

Despite Los Angeles Wildfires, CV Physicians ‘Rise to the Occasion’

Yael L. Maxwell

January 17, 2025

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

News Daily News

Global Commission Proposes ‘Radical’ Overhaul of Obesity Diagnosis

L.A. McKeown

January 14, 2025

News Daily News

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Michael O'Riordan

January 13, 2025

News Daily News

Just One in Five Grand Rounds Lectures Given by Women

Michael O'Riordan

January 07, 2025

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

News Opinion Editor's Corner

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Shelley Wood

January 01, 2025

News Daily News

Top Heart Failure News of 2024

Todd Neale

December 31, 2024

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Daily News

Radial Artery Best for Secondary Access During TAVI: PULSE Registry

Michael O'Riordan

December 23, 2024

News Daily News

PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits

Michael O'Riordan

December 18, 2024

News Daily News

Editor’s Pick: TCTMD’s Best Long Reads of 2024

Shelley Wood

December 17, 2024

News Daily News

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Michael O'Riordan

December 06, 2024

News Daily News

Palliative Care in HF: Practical Advice From the HFSA

Caitlin E. Cox

December 05, 2024

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Michael O'Riordan

December 05, 2024

News Daily News

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

Michael O'Riordan

December 04, 2024

News Conference News PCR London Valves 2024

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Michael O'Riordan

December 03, 2024

News Conference News PCR London Valves 2024

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Michael O'Riordan

December 02, 2024

Advertisement

Surgeons Formalize Support for ESC’s Stance on CCS Revascularization

Misleading Statements Common in Online Ads for Compounded GLP-1s

Despite Los Angeles Wildfires, CV Physicians ‘Rise to the Occasion’

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Global Commission Proposes ‘Radical’ Overhaul of Obesity Diagnosis

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Just One in Five Grand Rounds Lectures Given by Women

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

TCTMD’s Biggest News of 2024: Stories, Videos, and More

Top Heart Failure News of 2024

Top Coronary Artery Disease News in 2024

Radial Artery Best for Secondary Access During TAVI: PULSE Registry

PREDIMED Analysis May Rekindle Hope for Wine’s Heart Benefits

Editor’s Pick: TCTMD’s Best Long Reads of 2024

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Palliative Care in HF: Practical Advice From the HFSA

Sustained Benefit With Pascal TEER Device at 2 Years: CLASP IID and MiCLASP

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

Reverse Remodeling and Higher Stroke Volume With TEER: TRILUMINATE

Electrical Variables, Not Valve Type, Predict Need for Pacemaker After TAVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content